Delivery Order 36C24925D0012-36C24925N0488
Award Date
4/7/25
Potential Completion Date
9/30/25
Potential Value
$397K
Federal Agency
Veterans Integrated Service Network 9
Awardee
Pharmalogic Holdings Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40502, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. that specializes in innovative diagnostic imaging agents and targeted oncology therapies. The contract, valued at $124,296.48, was awarded by the Veterans Integrated Service Network 12 (VISN 12)...
This is a firm fixed price delivery order contract awarded by the Veterans Integrated Service Network 8 (VISN 8), a component of the Department of Veterans Affairs (VA), to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract is for the supply of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used for the detection of prostate cancer through positron emission tomography (PET) scans. The contract has a ceiling value of $631,526.00 and a period of...
This is a $2,056,970.40 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has an ultimate completion date of August 31, 2027 and was...
This is a firm fixed-price delivery order contract awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The contract, valued at $1,466,705.44, is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has an ultimate completion date of October 31,...
This is a federal contract award to Pharmalogic Holdings Corp., a for-profit company based in Boca Raton, Florida, to provide single-dose radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $96,546.45 and is a delivery order contract with a firm fixed price. The ultimate completion date is February 28, 2025. This contract is not a set-aside award. Pharmalogic Holdings Corp. specializes in supplying radiopharmaceuticals and related products to...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract provides for the delivery of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has a ceiling value of $1,100,659.60 and a period of performance ending on September 30, 2025. This order is placed under...
This federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, is for the delivery of single-dose radiopharmaceuticals to support nuclear medicine diagnostic imaging procedures at U.S. Department of Veterans Affairs (VA) medical facilities across Veterans Integrated Service Network (VISN) 23. The $56,752.27 firm-fixed-price delivery order was awarded on October 1, 2022, with a completion date of September 30, 2023. Pharmalogic Puerto Rico is a for-profit...
This is a federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc., a for-profit pharmaceutical company. The contract is for the delivery of F18 PIFLUFLOSTAT (PYLARIFY) unit doses, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract, valued at $3,628,720.00, was awarded by the Veterans Integrated Service Network 16...
This federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, was issued by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 23. The $45,404.73 firm-fixed-price delivery order is for the provision of single-dose radiopharmaceuticals and generator nuclear medicine products to support nuclear medicine diagnostic imaging procedures at VA medical facilities. This award is part of a larger $2,664,954.52...
This is a federal contract award to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., a subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY F-18 injections, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has a ceiling value of $1,212,529.92 and an ultimate completion date of August 31, 2026. The contract was awarded on September 1, 2025 and is a...